TY  - GEN
AU  - Ferrara,Felicetto
TI  - Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
SN  - 1099-1069
PY  - 2014///0425
KW  - Age Factors
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Azacitidine
KW  - Combined Modality Therapy
KW  - Comorbidity
KW  - Consolidation Chemotherapy
KW  - DNA Methylation
KW  - drug effects
KW  - DNA, Neoplasm
KW  - metabolism
KW  - DNA-Cytosine Methylases
KW  - antagonists & inhibitors
KW  - Decitabine
KW  - Enzyme Inhibitors
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Multicenter Studies as Topic
KW  - Neoplasm Proteins
KW  - Prognosis
KW  - Randomized Controlled Trials as Topic
KW  - Remission Induction
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Review
UR  - https://doi.org/10.1002/hon.2046
ER  -